From meeting regulatory requirements to minimizing contamination risks, GMP standards are the foundation of safe and effective cell therapies. Our latest blog reveals five critical reasons why GMP is vital for raw materials in cell therapy. Whether scaling up production or ensuring batch consistency, learn how GMP makes a difference. Read more: https://lnkd.in/gWvYS569
Bio-Techne
Biotechnology Research
Minneapolis, Minnesota 52,526 followers
Empowering scientists & clinicians by providing high-quality reagents, analytical instruments, & precision diagnostics.
About us
Bio-Techne is headquartered in Minneapolis, Minnesota and employs over 3,000 people globally at 34 locations worldwide. As a global developer, manufacturer and supplier of high-quality reagents, analytical instruments and precision diagnostics, Bio-Techne has an extensive catalog of over 500,000 products. Incorporated in 1981 as R&D Systems, the company changed its name to Bio-Techne in 2014. Our growth has been accelerated through acquisitions, organic investments, diversification of our customer base and expansion into new markets. In fiscal year 2023, Bio-Techne delivered net sales of over $1.1 billion. Bio-Techne includes the following brands: ACD, Asuragen, ExosomeDx, Lunaphore, Novus Biologicals, ProteinSimple, R&D Systems and Tocris Bioscience.
- Website
-
http://www.bio-techne.com/
External link for Bio-Techne
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- Minneapolis, Minnesota
- Type
- Public Company
Locations
-
Primary
614 McKinley Place NE
Minneapolis, Minnesota 55413, US
Employees at Bio-Techne
-
Brett Houser
-
Geoffrey Grove (林杰富)
Senior Product Manager
-
Andrew Stobbe
Senior IT Manager & DevOps SRE Leader | Driving Innovation in Web Ops & Platform Development
-
Kurt Donner
Business Leader - Spatial Genomics & Multiomics - Gene Therapy - Cell Therapy - RNAi/ASO - Biomarkers - Single-cell Biology - Life Sciences - Biotech…
Updates
-
🎙️ Prepare to be inspired by the groundbreaking work of Dr. Johan Skog! Listen Now: https://apple.co/4guMNtK & https://bit.ly/3ZoXIQ1 In this episode of #BackOfTheNapkin, Johan shares transformative insights into exosome research and its impact on non-invasive liquid biopsies. Tune in now to discover the future of diagnostics! #Exosomes #Diagnostics #ProstateCancer #LiquidBiopsy
-
This holiday season we’re celebrating our people, our #EPICscience, and the exciting opportunities ahead of us as we get ready to catalyze advances in science and medicine in 2025.
-
Are you attending #ATW25? Our team of experts will be there! Schedule a meeting with us through Phacilitate’s Meeting App. Learn more about our team here: https://bit.ly/3VNCc5o We can't wait to connect with you and discuss the latest industry trends!
-
🎙️ Heart disease is the leading cause of death worldwide, but Dr. Doris Taylor is changing the game with her bioengineered hearts. In this episode #BackOfTheNapkin, https://apple.co/3D1Y4mN and https://bit.ly/49t3y6n, Doris shares her inspiring journey and discusses her groundbreaking advancements in regenerative medicine, including the development of the first bioartificial heart. Tune in to experience this compelling story of innovation and perseverance! #HeartDisease #RegenerativeMedicine #Bioengineering
-
🎙️ Listen Now: https://apple.co/3D1Y4mN & https://bit.ly/4f9TNLu "The first life we save will change everything." - Doris Taylor With heart disease as the leading cause of death, the need for viable heart transplants is more urgent than ever. Dr. Doris Taylor’s pioneering work developing the first beating bioartificial heart offers hope for countless patients awaiting life-saving transplants. In this episode of #BackofTheNapkin, Doris shares her journey from personal motivations to her groundbreaking achievements in regenerative medicine. Key Takeaways: • Development of the first beating bioartificial heart. • Addressing the unmet need for donor hearts. • Revolutionizing transplant medicine with innovative techniques. Be inspired by Doris’s journey in science! #RegenerativeMedicine #Bioengineering #HeartDisease
-
Streamline experiments and cut costs with a single recombinant protein that stimulates the Wnt signaling pathway. Read the App Note https://bit.ly/4fp39D6
-
🎙️ Listen Now: https://apple.co/3D1Y4mN & https://bit.ly/3VLMClY With heart disease as the world’s leading cause of death, Dr. Doris Taylor is offering new hope through her groundbreaking work in bioengineering hearts. Tune into Back of the Napkin to hear Dr. Taylor share her inspiring journey and the cutting- edge science behind the first beating bioartificial heart, a milestone in regenerative medicine. Don’t miss this inspiring episode—discover the future of heart transplants! #BackOfTheNapkin #BioTechne #HeartDisease #Innovation #SciencePodcast #RegenerativeMedicine #Bioengineering #TransplantInnovation #Cardiology
-
How do charge variants impact the binding kinetics of a biotherapeutic? Our latest application note, developed in collaboration with Nicoya, uncovers the answer by using an innovative workflow that combines icIEF fractionation on the MauriceFlex™ system and SPR analysis on the Alto™ System (Nicoya). This approach allowed us to analyze the binding behavior of individual charge variants in a therapeutic bispecific antibody and a research-grade biosimilar. The findings are fascinating - learn more in the application note! Download: https://bit.ly/3Bsikh7 #Biotherapeutics #BindingKinetics #ProteinCharacterization #icIEF #SPR
-
🎙️ Dive into this episode of Back of the Napkin and listen now https://apple.co/3OgetGu & https://bit.ly/3ZaxS0C, where Professor Kevan Shokat reveals the pivotal moments that have shaped his career. Hear the story behind targeting the so-called "undruggable" KRAS and discover the new challenges that have captured Kevan’s focus. Learn how his work in drug discovery is revolutionizing cancer treatment. Key Takeaways: ▪️ Kevan's career blends chemistry and biology to tackle ‘impossible’ challenges like targeting "undruggable" proteins. ▪️ Success comes from breaking complex problems into manageable steps. ▪️ Collaboration is central to advancing scientific research. Get inspired by Kevan’s journey in science! #BackOfTheNapkin #BioTechne #CancerTherapy #Innovation #KRAS #SciencePodcast #DrugDiscovery #OncologyResearch #KRASInhibitors